Aldehyde dehydrogenase (ALDH) has been proposed together with CD133 to identify the CSC population in hepatocellular carcinoma [11] and ALDH+ cells are seems to be capable of directly generating tumors in vivo [10]. The gene discussed is LDHA; the disease is hepatocellular carcinoma.